What is Design Therapeutics, Inc.'s total revenue?

Design Therapeutics, Inc. (DSGN) reported total revenue of $0 in Q1 2026.

What does total revenue mean?

The aggregate of all revenue from the company's operations — the top line from which all profitability metrics are derived.

Design Therapeutics, Inc. DSGN Total Revenue

Total Revenue at other companies

ALN

Alnylam PharmaceuticalsALNY

$1.17B+96.4%

Intellia TherapeuticsNTLA

$15.05M-9.5%

CRISPR TherapeuticsCRSP

$1.46M+68.6%

Taysha Gene Therapies, Inc.TSHA

$0-100%

Sarepta Therapeutics, Inc.SRPT

$730.8M-1.9%

Stoke Therapeutics, Inc.STOK

$6.23M-96.1%

Other financials

Income statement

See full

Operating income-$19.7M+3.5%

Net income-$17.6M+0.4%

EPS (diluted)-$0.29+6.5%

Balance sheet

See full

Cash & equivalents$12.8M-6.6%

Total debt$2.7M+27.7%

Total equity$218.1M-4.3%

Total assets$230.4M-3.0%

Cash flow

See full

Operating cash flow-$16.4M+2.1%

CapEx--100%

Free cash flow-$16.4M+2.6%

Valuation

See full

Market cap$860.66M+305%

Enterprise value$850.62M+324%

Profitability

See full

Operating margin-3,685.8%—

Net margin-3,663.7%—

Returns & leverage

See full

Return on equity-31.3%+19.5pp

Debt / equity0×0.0×

Current ratio22.3×-6.1×

Where this comes from

Reported directly by Design Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:Revenues.

The official record: Design Therapeutics, Inc.’s 10-Q, filed April 28, 2026, on SEC EDGAR. View the filing →

Ask your AI about Design Therapeutics, Inc.'s total revenue.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Design Therapeutics, Inc.'s total revenue?: Design Therapeutics, Inc. (DSGN) reported total revenue of $0 in Q1 2026.
What does total revenue mean?: The aggregate of all revenue from the company's operations — the top line from which all profitability metrics are derived.